PMCB PharmaCyte Biotech, Inc. - Common Stock
$0,53
Precio · Ago 19, 2026
Fundamentales a fecha de Jul 29, 2026
Rango 52S
$1–$2
3% of range
Calificación del Analista
HOLD
6 analysts
Precio Objetivo
—
P/E (TTM)
-0.2
ROE
-56.7%
Margen de Beneficio Neto
—
PMCB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$0.53
Capitalización Bursátil
$6M
P/E (TTM)
-0.2
BPA (TTM)
$-2.77
Ingresos (TTM)
$0
Rendimiento div.
—
ROE
-56.7%
Deuda/Capital
—
Rango 52S
$1 – $2
PMCB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$0
2017-04-30
→
2026-04-30
BPA
$-2.77
2021-04-30
→
2026-04-30
Flujo de caja libre
—
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
PMCB
Mediana de Pares
P/E (TTM)
-0.2
—
P/B (P/C)
0.2
1.0
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
PMCB
Mediana de Pares
ROA
-38.1%
-105.1%
ROE
-56.7%
-142.1%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
PMCB
Mediana de Pares
Current Ratio (Ratio corriente)
45.3
1.6
Quick Ratio (Ratio Rápido)
22.8
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
PMCB
Mediana de Pares
Net Income YoY (Beneficio Neto interanual)
9085.0%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
PMCB
Mediana de Pares
PMCB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
VENTA
6 analistas
- Compra fuerte 0 0,0%
- Compra 0 0,0%
- Mantener 3 50,0%
- Venta 1 16,7%
- Venta fuerte 2 33,3%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Próximo informe
Sep 14, 2026
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.09 | — | — |
| 30 de septiembre de 2025 | $-0.10 | — | — |
| 30 de junio de 2025 | $-0.29 | — | — |
| 31 de marzo de 2025 | $0.14 | — | — |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| PMCB | $8M | -0.3 | — | — | -56.7% | — |
| AQB | $4M | -0.2 | -21.2% | — | -315.5% | — |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | — |
| CDIO | — | — | — | — | — | — |
| DRMA | — | — | — | — | — | — |
| XBIO | — | -1.4 | 19.0% | — | — | — |
| BRTX | $10M | -0.7 | -10.3% | -3959.4% | -547.6% | 93.4% |
| BCAB | — | -0.6 | — | — | — | — |
| LABT | — | — | — | — | — | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| R&D Expense | $391.3K | $438.4K | $407.4K | $468.5K | $690.9K | $916.2K | $301.2K | $460.1K | $2M | $1M | $1M | $3M | |
| SG&A Expense | $5M | $4M | $6M | $1M | $1M | $418.1K | $1M | $1M | $2M | $744.8K | $2M | $2M | |
| Operating Expenses | $7M | $4M | $9M | $6M | $4M | $4M | $4M | $4M | $7M | $4M | $6M | $13M | |
| Operating Income | $-7M | $-4M | $-9M | $-6M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | $-13M | |
| Interest Expense | · | · | · | $0 | $509 | $3.0K | $453 | $0 | $0 | $1.5K | $1.2K | $4.9K | |
| Other Non-op | $-980 | $-965 | $191.1K | $202.0K | $-4.3K | $71.7K | $-493 | $33.4K | $152.6K | $-1.5K | $9.3K | $3M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $31M | $333.8K | $-4M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | $-10M | |
| EPS (Basic) | $-2.77 | $3.19 | $-1.80 | $-0.22 | $-0.27 | $-2.45 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.77 | $3.19 | $-1.80 | $-0.22 | $-0.27 | $-2.45 | · | · | · | · | · | · | |
| Shares (Basic) | 8,378,291 | 7,329,596 | 9,581,059 | 19,489,204 | 15,521,654 | 1,448,285 | 903,812 | 1,100,104,338 | 968,641,686 | 845,308,413 | 752,403,049 | 704,327,656 | |
| Shares (Diluted) | 8,378,291 | 7,329,596 | 9,581,059 | 19,489,204 | 15,521,654 | 1,448,285 | 903,812 | 1,100,104,338 | 968,641,686 | 845,308,413 | 752,403,049 | 704,327,656 | |
| EBITDA | $-7M | $-4M | $-9M | $-6M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | · |
Balance general 19
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $15M | $50M | $68M | $85M | $2M | $894.9K | $515.3K | $1M | $3M | $2M | $3M | |
| Short-term Investments | $254.0K | $366.3K | $0 | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $96.9K | $223.8K | $259.8K | $107.7K | $94.2K | $73.1K | $142.8K | $138.2K | $224.1K | $74.3K | $110.0K | $1M | |
| Current Assets | $37M | $22M | $50M | $68M | $85M | $2M | $1M | $653.4K | $1M | $4M | $2M | $4M | |
| Intangibles | $0 | $2M | $2M | $4M | $4M | · | · | · | · | · | · | · | |
| Other Non-current Assets | $7.7K | $7.7K | · | · | · | $7.4K | $7.4K | $7.4K | $7.4K | $7.4K | $7.9K | $7.9K | |
| Total Assets | $47M | $55M | $60M | $73M | $91M | $7M | $6M | $6M | $6M | $9M | $7M | $9M | |
| Accounts Payable | $271.1K | $399.2K | $389.4K | $128.3K | $205.4K | $172.3K | $185.8K | $121.9K | $352.6K | $365.6K | $336.0K | $496.7K | |
| Accrued Liabilities | $522.8K | $3M | $735.2K | $458.3K | $499.0K | $552.5K | $816.6K | $621.0K | $291.5K | $214.6K | $151.6K | $23.7K | |
| Current Liabilities | $826.4K | $3M | $7M | $586.6K | $704.4K | $724.8K | $1M | $742.9K | $644.2K | $580.2K | $637.6K | $2M | |
| Total Liabilities | $12M | $3M | $20M | $586.6K | $704.4K | $724.8K | $1M | $742.9K | $644.2K | $580.2K | $637.6K | $2M | |
| Common Stock | $2.6K | $2.2K | $2.2K | $2.2K | $2.1K | $159 | $109 | $118.6K | $101.3K | $90.5K | $78.1K | $73.3K | |
| Paid-in Capital | $183M | $181M | $185M | $202M | $202M | $114M | $109M | $105M | $102M | $97M | $91M | $86M | |
| Retained Earnings | $-104M | $-85M | $-116M | $-116M | $-112M | $-107M | $-104M | $-100M | $-96M | $-89M | $-85M | $-79M | |
| Treasury Stock | $45M | $45M | $42M | $14M | $0 | · | · | · | · | · | · | · | |
| AOCI | $-20.8K | $-23.9K | $-23.5K | $-23.0K | $-15.8K | $-20.4K | $-21.7K | $-13.8K | $-4.7K | $1.7K | $806 | $1.5K | |
| Stockholders' Equity | $33M | $52M | $28M | $73M | $90M | $7M | $5M | $5M | $6M | $8M | $7M | $8M | |
| Liabilities + Equity | $47M | $55M | $60M | $73M | $91M | $7M | $6M | $6M | $6M | $9M | $7M | $9M | |
| Shares Outstanding | 10,735,649 | 6,795,779 | 8,037,624 | 16,793,980 | 20,721,047 | 1,590,084 | 1,092,425 | 1,186,004,505 | 1,013,260,644 | 905,349,047 | 781,233,338 | 732,760,536 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $892.5K | $0 | $674.7K | $7.3K | $33.1K | $194.3K | $368.6K | $293.3K | $580.4K | $420.5K | $405.1K | $735.2K | |
| Operating Cash Flow | $-5M | $-3M | $-2M | $-4M | $-4M | $-3M | $-2M | $-3M | $-5M | $-3M | $-4M | $-5M | |
| Investing Cash Flow | $2M | $-7M | $-5M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Stock Issued | · | · | · | $0 | $87M | $5M | $3M | $2M | $3M | $5M | $4M | $4M | |
| Stock Repurchased | $401.6K | $3M | $28M | $14M | $0 | · | · | · | · | · | · | · | |
| Net Stock Activity | $-401.6K | $-3M | $-28M | $-14M | $87M | $5M | $3M | $2M | $3M | $5M | $4M | · | |
| Financing Cash Flow | $7M | $-25M | $-11M | $-14M | $87M | $5M | $3M | $2M | $3M | $5M | · | · | |
| Net Change in Cash | $3M | $-35M | $-18M | $-17M | $83M | $1M | $379.6K | · | · | · | · | · | |
| Taxes Paid | $0 | $0 | $1.6K | $0 | $1.6K | $800 | $800 | $800 | $800 | $800 | · | · |
Rentabilidad 2
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -38.1% | 53.3% | 0.50% | -5.3% | -8.6% | -52.3% | -64.0% | -66.7% | -90.6% | -56.1% | -73.7% | · | |
| ROE | -56.7% | 66.5% | 1.1% | -5.8% | -4.7% | -49.7% | -81.3% | -78.2% | -117.7% | -60.8% | -84.8% | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 45.3 | 7.7 | 6.8 | 116.2 | 121.4 | 3.1 | 1.0 | 0.9 | 2.0 | 6.1 | 3.2 | · | |
| Quick Ratio | 22.8 | 5.3 | 6.8 | 116.0 | 121.2 | 3.0 | 0.9 | 0.7 | 1.6 | 6.0 | 3.0 | · | |
| Interest Coverage | · | · | · | · | -8628.7 | -1189.4 | -8446.8 | · | · | -2886.4 | -5099.2 | · |
Eficiencia 1
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
Tasas de Crecimiento 1
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income YoY | · | 9085.0% | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 8
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-19M | $31M | $333.8K | $-4M | $-4M | $-4M | $-4M | $-4M | $-7M | $-4M | $-6M | $-10M | |
| Market Cap | $8M | $8M | $17M | $49M | $4M | $44M | $62.23B | $75.37B | $84.81B | $109.32B | $82.95B | · | |
| P/E | -0.3 | 0.4 | -1.2 | -13.3 | -8.6 | -11.2 | · | · | · | · | · | · | |
| P/B | 0.2 | 0.2 | 0.6 | 0.7 | 0.0 | 6.5 | 12227.9 | 14955.8 | 14701.8 | 13517.1 | 12716.8 | · | |
| P / Tangible Book | 0.2 | 0.2 | 0.7 | 0.7 | 0.0 | 6.5 | 12227.9 | · | · | · | · | · | |
| P / Cash Flow | -1.5 | -2.8 | -7.9 | -12.9 | -0.9 | -13.1 | -26611.4 | -26189.3 | -16696.9 | -32734.7 | -19084.1 | · | |
| Earnings Yield | -383.7% | 257.3% | -84.9% | -7.5% | -11.6% | -8.9% | · | · | · | · | · | · |
Estado de resultados 13
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $61.9K | $93.1K | $141.1K | $95.2K | $126.7K | $118.2K | $97.5K | $96.0K | $94.2K | $126.7K | $82.0K | $104.5K | $85.9K | $45.4K | $178.0K | $159.3K | |
| SG&A Expense | $899.9K | $2M | $1M | $753.1K | $915.9K | $842.1K | $1M | $1M | $4M | $251.9K | $272.5K | $1M | $328.1K | $356.9K | $183.0K | $244.7K | |
| Operating Expenses | $3M | $2M | $1M | $848.3K | $1M | $960.3K | $1M | $1M | $3M | $2M | $1M | $2M | $903.3K | $2M | $2M | $2M | |
| Operating Income | $-3M | $-2M | $-1M | $-848.3K | $-1M | $-960.3K | $-1M | $-1M | $-3M | $-2M | $-1M | $-2M | $-903.3K | $-2M | $-2M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| Other Non-op | $-132 | $-632 | $-95 | $-121 | $687 | $-400 | $-1.1K | $-190 | $194.0K | $-253 | $-765 | $-1.8K | $54.0K | $153.0K | $-1.1K | $-3.9K | |
| Net Income | $-4M | $746.9K | $-7M | $-8M | $12M | $-3M | $-1M | $23M | $1M | $-619.5K | $3M | $-3M | $-126.3K | $-764.1K | $-2M | $-2M | |
| EPS (Basic) | $-0.13 | $-0.17 | $-1.24 | $-1.23 | $2.12 | $-0.44 | $-0.39 | $1.90 | $-0.35 | $-0.65 | $-0.26 | $-0.54 | $-0.02 | $-0.04 | $-0.09 | $-0.07 | |
| EPS (Diluted) | $-0.13 | $-0.17 | $-1.24 | $-1.23 | $2.12 | $-0.44 | $-0.39 | $1.90 | $-0.35 | $-0.65 | $-0.26 | $-0.54 | $-0.02 | $-0.04 | $-0.09 | $-0.07 | |
| Shares (Basic) | -14,476,096 | 9,262,829 | 6,795,779 | 6,795,779 | -15,133,839 | 6,960,014 | 7,637,034 | 7,866,387 | -20,392,923 | 8,606,957 | 8,765,134 | 12,601,891 | -40,921,004 | 18,995,442 | 20,585,451 | 20,829,315 | |
| Shares (Diluted) | -14,476,096 | 9,262,829 | 6,795,779 | 6,795,779 | -15,133,839 | 6,960,014 | 7,637,034 | 7,866,387 | -20,392,923 | 8,606,957 | 8,765,134 | 12,601,891 | -40,921,004 | 18,995,442 | 20,585,451 | 20,829,315 | |
| EBITDA | · | $-2M | $-1M | $-848.3K | · | $-960.3K | $-1M | $-1M | · | $-2M | $-1M | $-2M | · | $-2M | $-2M | $-2M |
Balance general 19
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $20M | $15M | $13M | $15M | $16M | $21M | $33M | $50M | $61M | $73M | $75M | $68M | $73M | $77M | $82M | |
| Short-term Investments | $254.0K | $372.3K | $201.2K | $261.9K | $366.3K | $372.6K | · | · | $0 | · | · | · | · | · | · | · | |
| Prepaid Expense | $96.9K | $158.7K | $503.1K | $238.2K | $223.8K | $207.4K | $493.2K | $240.2K | $259.8K | $297.8K | $323.2K | $88.7K | $107.7K | $181.0K | $256.8K | $28.1K | |
| Current Assets | $37M | $21M | $23M | $19M | $22M | $17M | $21M | $33M | $50M | $62M | $74M | $75M | $68M | $73M | $77M | $82M | |
| Intangibles | $0 | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $4M | $4M | $4M | · | · | · | |
| Other Non-current Assets | $7.7K | · | · | · | $7.7K | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $47M | $56M | $56M | $45M | $55M | $44M | $55M | $70M | $60M | $71M | $79M | $80M | $73M | $78M | $82M | $87M | |
| Accounts Payable | $271.1K | $1M | $1M | $465.2K | $399.2K | $484.9K | $348.6K | $554.0K | $389.4K | $484.2K | $126.2K | $718.1K | $128.3K | $445.9K | $861.3K | $559.0K | |
| Accrued Liabilities | $522.8K | $445.7K | $520.7K | $595.7K | $3M | $709.4K | $707.2K | $684.1K | $735.2K | $774.4K | $1M | $480.0K | $458.3K | $381.9K | $449.9K | $530.3K | |
| Current Liabilities | $826.4K | $2M | $2M | $1M | $3M | $1M | $5M | $7M | $7M | $8M | $5M | $2M | $586.6K | $827.8K | $1M | $1M | |
| Total Liabilities | $12M | $16M | $19M | $2M | $3M | $4M | $12M | $17M | $20M | $22M | $21M | $20M | $586.6K | $827.8K | $1M | $1M | |
| Common Stock | $2.6K | $2.6K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | $2.2K | |
| Paid-in Capital | $183M | $183M | $181M | $182M | $181M | $181M | $181M | $183M | $185M | $189M | $194M | $202M | $202M | $202M | $202M | $202M | |
| Retained Earnings | $-104M | $-100M | $-101M | $-93M | $-85M | $-97M | $-94M | $-92M | $-116M | $-117M | $-116M | $-119M | $-116M | $-116M | $-115M | $-113M | |
| Treasury Stock | $45M | $45M | $45M | $45M | $45M | $44M | $44M | · | $42M | $41M | $40M | $40M | $14M | $9M | $5M | $2M | |
| AOCI | $-20.8K | $-21.5K | $-24.1K | $-23.7K | $-23.9K | $-24.5K | $-23.3K | $-23.3K | $-23.5K | $-23.1K | $-24.1K | $-22.6K | $-23.0K | $-17.7K | $-15.2K | $-14.5K | |
| Stockholders' Equity | $33M | $38M | $35M | $44M | $52M | $40M | $43M | $48M | $28M | $31M | $37M | $43M | $73M | $77M | $81M | $86M | |
| Liabilities + Equity | $47M | $56M | $56M | $45M | $55M | $44M | $55M | $70M | $60M | $71M | $79M | $80M | $73M | $78M | $82M | $87M | |
| Shares Outstanding | 10,735,649 | 10,735,649 | · | 6,795,779 | 6,795,779 | 6,904,894 | 7,034,259 | 7,717,278 | 8,037,624 | 8,521,159 | 8,699,992 | 8,778,101 | 16,793,980 | 18,209,018 | 19,526,944 | 20,750,068 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $0 | $771.5K | $60.5K | $60.5K | $0 | $-341.8K | $119.2K | $222.7K | $0 | $674.7K | $0 | $0 | $0 | $667 | $3.9K | $2.8K | |
| Operating Cash Flow | $-1M | $-786.8K | $-979.5K | $-2M | $-1M | $-509.9K | $-1M | $-373.3K | $-333.0K | $-177.1K | $-2M | $343.0K | $-288.4K | $-541.7K | $-2M | $-1M | |
| Investing Cash Flow | $0 | $5M | $-3M | $0 | $0 | $0 | $0 | $-7M | $0 | $-5M | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $-880 | $880 | |
| Stock Repurchased | $0 | $401.6K | $0 | $0 | $171.5K | $225.0K | $1M | $742.2K | $1M | $404.7K | $165.0K | $26M | $4M | $4M | $3M | $2M | |
| Net Stock Activity | · | · | · | $0 | · | · | · | $-742.2K | · | $-404.7K | $-165.0K | $-26M | · | · | · | $-2M | |
| Financing Cash Flow | $-169.8K | $543.8K | $6M | $0 | $-171.5K | $-4M | $-11M | $-10M | $-11M | $-7M | $748.7K | $6M | $-4M | $-4M | $-3M | $-2M | |
| Net Change in Cash | $-2M | $5M | $2M | $-2M | $-1M | $-4M | $-12M | $-18M | $-11M | $-12M | $-1M | $7M | $-5M | $-4M | $-5M | $-3M | |
| Taxes Paid | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $1.6K | $0 | $0 | $0 | $0 |
Rentabilidad 2
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | 1.5% | -13.4% | -14.5% | · | -5.3% | -2.2% | 31.2% | · | -0.83% | 3.5% | -3.8% | · | -0.90% | -2.1% | -3.3% | |
| ROE | · | 1.9% | -18.9% | -18.3% | · | -8.5% | -3.7% | 51.8% | · | -1.1% | 4.7% | -4.9% | · | -0.91% | -2.2% | -3.4% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 12.3 | 14.6 | 18.0 | · | 14.2 | 4.5 | 4.4 | · | 8.2 | 14.1 | 49.2 | · | 88.0 | 58.9 | 75.5 | |
| Quick Ratio | · | 12.2 | 9.9 | 12.7 | · | 14.0 | 4.4 | 4.4 | · | 8.1 | 14.0 | 49.2 | · | 87.7 | 58.7 | 75.5 |
Eficiencia 1
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
Valoración (TTM) 8
| Métrica | Tendencia | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Net Income TTM | · | $-18M | $-20M | $11M | · | $18M | $24M | $22M | · | $-2M | $-3M | $-7M | · | $-5M | $-5M | $-4M | |
| Market Cap | · | $9M | · | $7M | · | $11M | $13M | $15M | · | $19M | $18M | $23M | · | $53M | $57M | $50M | |
| P/E | · | -0.3 | -0.3 | -6.4 | · | 3.8 | 3.0 | 4.4 | · | -1.5 | -2.3 | -3.6 | · | -12.0 | -11.3 | -3.0 | |
| P/B | · | 0.2 | · | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.6 | 0.5 | 0.5 | · | 0.7 | 0.7 | 0.6 | |
| P / Tangible Book | · | 0.2 | · | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.7 | 0.6 | 0.6 | · | 0.7 | 0.7 | 0.6 | |
| P / Cash Flow | · | · | · | -3.5 | · | · | · | -40.5 | · | · | · | 68.1 | · | · | · | -45.7 | |
| Earnings Yield | · | -380.2% | -354.8% | -15.7% | · | 26.2% | 33.1% | 23.0% | · | -68.0% | -43.9% | -27.8% | · | -8.3% | -8.8% | -33.9% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | |
|---|---|---|---|---|---|
| Ingresos | $0 | $0 | $0 | $0 | $0 |
| Beneficio neto | $-19M | $31M | $333.8K | $-4M | $-4M |
| EPS Diluido | $-2.77 | $3.19 | $-1.80 | $-0.22 | $-0.27 |
Balance general
| 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | |
|---|---|---|---|---|---|
| Ratio corriente | 45.3 | 7.7 | 6.8 | 116.2 | 121.4 |
| Ratio Rápido | 22.8 | 5.3 | 6.8 | 116.0 | 121.2 |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 37 declarantes · $649K total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 5 (-6 vs trimestre anterior) | 5 (+1 vs trimestre anterior) | 3 (-3 vs trimestre anterior) | 10 (+4 vs trimestre anterior) | -279K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| CITADEL ADVISORS LLC | $218 203 | 283 381 | 33,62% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $80 235 | 104 187 | 12,36% | Acciones |
| CITADEL ADVISORS LLC | $66 297 | 86 100 | 10,22% | Opción de compra |
| VANGUARD CAPITAL MANAGEMENT LLC | $43 719 | 56 778 | 6,74% | Acciones |
| VANGUARD GROUP INC | $37 262 | 51 467 | 5,74% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $29 250 | 37 987 | 4,51% | Acciones |
| XTX Topco Ltd | $26 319 | 34 180 | 4,06% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25 994 | 33 759 | 4,01% | Acciones |
| NORTHERN TRUST CORP | $25 120 | 32 624 | 3,87% | Acciones |
| Schonfeld Strategic Advisors LLC | $20 733 | 26 926 | 3,19% | Acciones |
| JANE STREET GROUP, LLC | $20 470 | 26 585 | 3,15% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $18 058 | 23 452 | 2,78% | Acciones |
| EQUITEC PROPRIETARY MARKETS, LLC | $17 115 | 22 227 | 2,64% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $15 600 | 20 255 | 2,40% | Acciones |
| Tower Research Capital LLC (TRC) | $3 764 | 4 888 | 0,58% | Acciones |
| GROUP ONE TRADING LLC | $385 | 500 | 0,06% | Acciones |
| OSAIC HOLDINGS, INC. | $231 | 302 | 0,04% | Acciones |
| BARCLAYS PLC | $148 | 192 | 0,02% | Acciones |
| UBS Group AG | $23 | 30 | 0,00% | Acciones |
| Sachetta, LLC | $11 | 14 | 0,00% | Acciones |
| HRT FINANCIAL LP | $11 | 15 451 | 0,00% | Acciones |
| SBI Securities Co., Ltd. | $5 | 6 | 0,00% | Acciones |
| BFSG, LLC | $4 | 5 | 0,00% | Acciones |
| CoreCap Advisors, LLC | $3 | 4 | 0,00% | Acciones |
| CALDWELL SUTTER CAPITAL, INC. | $2 | 2 | 0,00% | Acciones |
| HARBOUR INVESTMENTS, INC. | $2 | 3 | 0,00% | Acciones |
| FINANCIAL CONSULATE, INC | $2 | 2 | 0,00% | Acciones |
| NewEdge Advisors, LLC | $2 | 2 | 0,00% | Acciones |
| Johnson Financial Group, Inc. | $1 | 1 | 0,00% | Acciones |
| MCF Advisors LLC | $1 | 1 | 0,00% | Acciones |
| MORGAN STANLEY | $1 | 1 | 0,00% | Acciones |
| BlackRock, Inc. | $1 | 1 | 0,00% | Acciones |
| Abound Wealth Management | $1 | 1 | 0,00% | Acciones |
| Accredited Wealth Management, LLC | $1 | 50 | 0,00% | Acciones |
| CWM, LLC | $1 | 1 | 0,00% | Acciones |
| Covestor Ltd | $0 | 275 | 0,00% | Acciones |
| HUNTINGTON NATIONAL BANK | $0 | 1 | 0,00% | Acciones |
Informantes de la empresa 4 insiders · 0 directivos · 4 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Michael M Abecassis | Consejero | 31 de marzo de 2026 J | — | 0 | 0 | $0 |
| Jonathan Schechter | Consejero | 31 de marzo de 2026 J | — | 0 | 0 | $0 |
| Wayne Remell Walker | Consejero | 31 de marzo de 2026 J | — | 0 | 0 | $0 |
| Robert Weinstein | Consejero | 31 de marzo de 2026 J | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. ×2 presentaciones | 18 de noviembre de 2025 | 74,00% | Enmienda | — | SEC |
| Iroquois Master Fund Ltd., Iroquois Capital Management, LLC, Iroquois Capital Investment Group LLC, Richard Abbe, Kimberly Page ×6 presentaciones | 16 de junio de 2023 | — | Presentación inicial | — | SEC |
| Nima Montazeri (1) 2 (a) (b), Silver Rock Associates, Inc. (1) 2 (a) (b), Brown Stone Capital, LP (1) 2 (a) (b) ×2 presentaciones | 29 de julio de 2020 | — | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |